$4.93
1.40% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
US19516Q2084
Symbol
CLGN
Sector
Industry

Collplant Holdings ADR Stock price

$4.93
-0.18 3.52% 1M
-0.30 5.74% 6M
-1.46 22.85% YTD
-0.67 11.96% 1Y
-11.59 70.16% 3Y
+0.92 22.94% 5Y
-13.54 73.30% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
-0.07 1.40%
ISIN
US19516Q2084
Symbol
CLGN
Sector
Industry

Key metrics

Market capitalization $57.27m
Enterprise Value $41.50m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 60.14
P/S ratio (TTM) P/S ratio 83.00
P/B ratio (TTM) P/B ratio 2.76
Revenue growth (TTM) Revenue growth -93.61%
Revenue (TTM) Revenue $690.00k
EBIT (operating result TTM) EBIT $-18.41m
Free Cash Flow (TTM) Free Cash Flow $-3.44m
Cash position $19.16m
EPS (TTM) EPS $-1.53
P/E forward negative
P/S forward 33.93
EV/Sales forward 24.59
Short interest 0.12%
Show more

Is Collplant Holdings ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Collplant Holdings ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Collplant Holdings ADR forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Collplant Holdings ADR forecast:

Buy
100%

Financial data from Collplant Holdings ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
0.69 0.69
94% 94%
100%
- Direct Costs 3.23 3.23
35% 35%
468%
-2.54 -2.54
130% 130%
-368%
- Selling and Administrative Expenses 3.86 3.86
7% 7%
559%
- Research and Development Expense 11 11
8% 8%
1,581%
-17 -17
195% 195%
-2,509%
- Depreciation and Amortization 1.10 1.10
2% 2%
159%
EBIT (Operating Income) EBIT -18 -18
163% 163%
-2,667%
Net Profit -17 -17
160% 160%
-2,532%

In millions USD.

Don't miss a Thing! We will send you all news about Collplant Holdings ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Collplant Holdings ADR Stock News

Neutral
Seeking Alpha
about one month ago
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN ) Q2 2024 Earnings Conference Call August 20, 2024 10:00 AM ET Company Participants Dan Ferry - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Conference Call Participants Sean Lee - H.C.
Neutral
PRNewsWire
about one month ago
- Recently initiated a pre-clinical trial with CollPlant's rhCollagen-based regenerative breast implants, printed with Stratasys' Origin ® 3D printer that are 200cc in volume - Breast implants could address a $3.0 billion market opportunity - Cash and cash equivalents balance as of June 30, 2024 was $18.9 million - Conference call to be held today at 10:00 a.m. U.S. EDT REHOVOT, Israel , Aug. 2...
Neutral
Business Wire
about one month ago
REHOVOT, Israel & EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--In a significant step in the advancement of regenerative medicine, CollPlant Biotechnologies (Nasdaq: CLGN) and Stratasys Ltd. (Nasdaq: SSYS) today announced the initiation of a pre-clinical study with 200cc commercial-sized regenerative implants printed on a Stratasys Origin® 3D printer. The collaboration between CollPlant and Stratasys i...
More Collplant Holdings ADR News

Company Profile

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The company's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Yehiel Tal
Employees 75
Founded 2004
Website www.collplant.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today